SCHEMBL6801065

SCHEMBL6801065

O=c1c2cc(F)c(F)cc2n(-c2ccc(F)cc2)c(=O)n1OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
TSHR P16473 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALOX15 P16050 1/20 0.38
MAPK8 P45983 2/20 0.38
MAPK9 P45984 2/20 0.38
POLB P06746 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 2/20 0.36
HBB P68871 1/20 0.36
NPC1 O15118 1/20 0.35
CYP2C19 P33261 1/20 0.35
GRM5 P41594 2/20 0.35
GRM3 Q14832 1/20 0.35
CTSV O60911 1/20 0.34
CTSL P07711 1/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MET P08581 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6796203 0.92 ALDH1A1 (0.40) ALDH1A1TSHRL3MBTL1ALOX15MAPK8
SCHEMBL6802703 0.89 ALDH1A1 (0.41) ALDH1A1TSHRL3MBTL1ALOX15MAPK8
SCHEMBL6801629 0.87 MAPT (0.41) ALDH1A1TSHRALOX15MAPK8MAPK9
SCHEMBL6800538 0.87 THRB (0.41) ALDH1A1TSHRL3MBTL1KMT2AKDM4E
SCHEMBL6799569 0.86 GLA (0.41) ALDH1A1TSHRL3MBTL1ALOX15KDM4E
SCHEMBL6800550 0.86 ALDH1A1 (0.42) ALDH1A1TSHRL3MBTL1ALOX15POLB
SCHEMBL6798162 0.85 ALDH1A1 (0.41) ALDH1A1TSHRL3MBTL1ALOX15MAPK8
SCHEMBL6800569 0.84 MEN1 (0.47) ALDH1A1TSHRL3MBTL1POLBKMT2A
SCHEMBL6799704 0.84 GNRHR (0.44) MAPK8POLBMAPTSMN1; SMN2
SCHEMBL6798905 0.81 ALDH1A1 (0.42) ALDH1A1TSHRL3MBTL1MAPK8MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1028950-B1 7-SUBSTITUTED QUINAZOLIN-2,4-DIONES USEFUL AS ANTIBACTERIAL AGENTS WARNER LAMBERT CO (US) 2003-05-02 EP claimed
US-20020115674-A1 Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents DOMAGALA JOHN MICHAEL (US) 2002-08-22 US claimed
US-6825199-B2 7-Substituted quinazolin-2,4-diones useful as antibacterial agents WARNER-LAMBERT COMPANY 2004-11-30 US disclosed
EP-1028950-B1 7-SUBSTITUTED QUINAZOLIN-2,4-DIONES USEFUL AS ANTIBACTERIAL AGENTS WARNER LAMBERT CO (US) 2003-05-02 EP disclosed
US-20020115674-A1 Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents DOMAGALA JOHN MICHAEL (US) 2002-08-22 US disclosed
US-6331538-B1 TREATMENT OF BACTERIAL INFECTION WARNER-LAMBERT COMPANY 2001-12-18 US disclosed
EP-1028950-A1 NOVEL 7-SUBSTITUTED QUINAZOLIN-2,4-DIONES USEFUL AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 2000-08-23 EP disclosed
WO-1999021840-A1 NOVEL 7-SUBSTITUTED QUINAZOLIN-2,4-DIONES USEFUL AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1999-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115674-A1 Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents NQO2, TOP1, TOP2A ALDH1A1 3064/4885TSHR 4720/4885L3MBTL1 4814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.